Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
ImmunityBio, Inc (IBRX)  
$2.64 0.06 (2.22%) as of 4:30 Mon 6/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 383,180,000
Market Cap: 1.01(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.89 - $6.7
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   ImmunityBio is a clinical-stage biotechnology company developing therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases. Co.'s platforms include: antibody cytokine fusion proteins, which include Anktiva, a class of biopharmaceuticals that enhance the therapeutic potential of cytokines, and promote lymphocyte infiltration at a site of disease, improving immune response; and DNA, RNA, and recombinant protein vaccine technologies, which are for infectious diseases to target viruses, including SARS-CoV-2, and for oncology to deliver common tumor-associated antigens, and neoepitopes (expressed only by cancer cells).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 211
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nant Capital, Llc See remarks   –       –       •   2025-02-22 4 D $3.42 $143,883 D/D (42,071) 29,546,190     -
   Nant Capital, Llc See remarks   –       –       •   2025-02-22 4 OE $0.00 $0 D/D 114,329 29,588,261     -
   Sachs David C. Chief Financial Officer   •       –      –    2025-02-22 4 D $3.42 $54,241 D/D (15,860) 225,620     -
   Sachs David C. Chief Financial Officer   •       –      –    2025-02-22 4 OE $0.00 $0 D/D 40,650 241,480     -
   Gallagher Regan J Chief Accounting Officer   •       –      –    2025-02-22 4 D $3.42 $5,708 D/D (1,669) 110,258     -
   Gallagher Regan J Chief Accounting Officer   •       –      –    2025-02-22 4 OE $0.00 $0 D/D 4,065 111,927     -
   Simon Barry J. Director   –       •      –    2025-02-22 4 D $3.42 $18,649 D/D (5,453) 3,243,571     -
   Simon Barry J. Director   –       •      –    2025-02-22 4 OE $0.00 $0 D/D 15,243 3,249,024     -
   Adcock Richard CEO & President   •       •      –    2025-02-22 4 D $3.42 $267,331 D/D (78,167) 334,418     -
   Adcock Richard CEO & President   •       •      –    2025-02-22 4 OE $0.00 $0 D/D 152,439 412,585     -
   Simon Barry J. Director   –       •      –    2025-01-22 4 OE $2.00 $219,864 D/D 110,020 3,233,781     -
   Sachs David C. Chief Financial Officer   •       –      –    2024-12-31 4 D $2.56 $39,437 D/D (15,405) 200,830     -
   Sachs David C. Chief Financial Officer   •       –      –    2024-12-31 4 OE $0.00 $0 D/D 30,397 216,235     -
   Adcock Richard CEO & President   •       •      –    2024-12-31 4 D $2.56 $44,736 D/D (17,475) 260,146     -
   Adcock Richard CEO & President   •       •      –    2024-12-31 4 OE $0.00 $0 D/D 34,483 277,621     -
   Nant Capital, Llc See remarks   –       –       •   2024-12-10 4 OE $1.94 $231,402,412 I/I 117,185,260 246,412,277     -
   Adcock Richard CEO & President   •       •      –    2024-02-05 4 D $4.04 $174,387 D/D (43,165) 243,138     -
   Adcock Richard CEO & President   •       •      –    2024-02-05 4 OE $0.00 $0 D/D 83,334 286,303     -
   Simon Barry J. Director   –       •      –    2024-01-31 4 D $3.36 $74,236 D/D (22,094) 3,123,761     -
   Simon Barry J. Director   –       •      –    2024-01-31 4 OE $0.00 $0 D/D 57,200 3,145,855     -
   Sachs David C. Chief Financial Officer   •       –      –    2024-01-31 4 D $3.36 $90,166 D/D (26,835) 185,838     -
   Sachs David C. Chief Financial Officer   •       –      –    2024-01-31 4 OE $0.00 $0 D/D 70,745 212,673     -
   Gallagher Regan J Chief Accounting Officer   •       –      –    2024-01-31 4 D $3.36 $45,259 D/D (13,470) 94,334     -
   Gallagher Regan J Chief Accounting Officer   •       –      –    2024-01-31 4 OE $0.00 $0 D/D 32,872 107,804     -
   Adcock Richard CEO & President   •       •      –    2023-12-31 4 D $5.02 $85,822 D/D (17,096) 202,969     -
  211 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us